https://drugnews.com.tw/articles/2026-08-16-obesity-drug-shakeout-pfizer-roche-amgen-en.html Drugnews｜藥時事 en 2026-08-16T00:00:00.000Z Pfizer Paid Billions for Obesity Assets. Is It Already Cutting Its Losses? https://drugnews.com.tw/articles/2026-08-16-obesity-drug-shakeout-pfizer-roche-amgen.html Drugnews｜藥時事 zh-tw 2026-08-16T00:00:00.000Z 百億美元搶來的減肥藥，輝瑞冤大頭又丟掉了？ https://drugnews.com.tw/articles/2026-08-15-gsk-camlipixant-calm-phase3-reproducibility-en.html Drugnews｜藥時事 en 2026-08-15T01:30:00.000Z GSK's US$2 Billion Cough-Drug Bet Hit a Phase 3 Reproducibility Wall https://drugnews.com.tw/articles/2026-08-15-gsk-camlipixant-calm-phase3-reproducibility.html Drugnews｜藥時事 zh-tw 2026-08-15T01:30:00.000Z GSK 砸 20 億美元買止咳新藥，三期卻翻車！